1st event of Synergy Translate Autism & Developmental Disabilities
A new platform at the Faculty of Medical and Health Sciences
Synergy Translate is a new platform at the Faculty of Medical and Health Sciences designed to synergize collaborations between basic researchers and clinicians.
One of the Synergy Clusters - Autism & Developmental Disabilities, took place on April 14, 2024. It’s goal is to bring together researchers from Tel Aviv campus, hospitals and community with special interest in autism and developmental disabilities, in order to promote collaborations, knowledge, translational research and multidisciplinary grant proposals.
Recent research advances in the area of brain development and autism are providing valuable insights into the causes, symptoms, and targeted treatments of this complex disorder. Many leading researchers from Tel Aviv University have contributed significantly to these advances. The rapid increase in the prevalence of autism spectrum-related disorders has made the developmental trajectories and neural basis of autism a focus of translational research. This research can inform early detection, early intervention strategies, and more precise treatments. By advancing our knowledge of autism, research can help reduce misconceptions associated with this disorder and promote the function, participation, and acceptance of individuals with autism and related disabilities.
After an introduction by Prof. Illana Gozes, Prof. David Cohen, MD, PhD from Sorbonne Université presented his research on Developmental genetics and new technologies in autism: current controversies.
This was followed by presentations from Prof. Lidia Gabis, Prof. Moran Rubinstein, Prof. Yoni Haitin and Prof. Lilach Shalev-Mevorach on various aspects of autism.
